Bank of New York Mellon Corp
BankPosition in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1390777
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$70,060,935
+$9,859,911 QoQ
Shares Held
859,538
-10.5% QoQ
Ownership
0.609%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ARWR ranks #16 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,060,935 | 859,538 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $60,201,024 | 960,144 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $58,944,224 | 887,848 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $28,093,756 | 814,548 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $12,925,645 | 818,079 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $9,886,734 | 776,039 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $15,605,088 | 830,058 | Shares | Other | 2025-02-04 | |
| 2024-09-30 | $16,782,145 | 866,399 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $28,200,938 | 1,085,069 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $30,172,509 | 1,054,983 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $29,311,919 | 957,906 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $26,618,170 | 990,628 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $36,910,378 | 1,035,064 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $26,415,820 | 1,039,993 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $43,281,936 | 1,067,109 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $35,489,582 | 1,073,815 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $36,497,696 | 1,036,572 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $48,047,586 | 1,044,740 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $69,200,689 | 1,043,751 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $66,140,399 | 1,059,433 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $89,898,705 | 1,085,471 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $67,346,820 | 1,015,636 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $79,574,453 | 1,037,071 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $45,672,488 | 1,060,671 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $47,349,063 | 1,096,297 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $30,657,251 | 1,065,598 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||